Page Title
Clinical Trial Finder
You can help advance cystic fibrosis research — starting now.
Tailor your search using the filters on the left.
Need help? Watch a video tutorial or contact the Clinical Trial Navigator, a real person who can assist you.
Showing 1-2 of 2 studies
Tailor your search using the filters on the left.
Need help? Watch a video tutorial or contact the Clinical Trial Navigator, a real person who can assist you.
Showing 1-2 of 2 studies
-
Mucociliary ClearanceCompleted with Results
Phase 3 study of inhaled mannitol in adults with cystic fibrosis , protocol number Pharmaxis DPM-CF-303This study evaluated the safety and effectiveness of the inhaled drug, Bronchitol® (mannitol).
-
Age:
18 Years and Older
-
Mutation(s):
No Mutation Requirement
-
FEV1% Predicted:
40 to 90%
-
Number of Visits:
5
-
Length of Participation:
6 months
-
-
Mucociliary ClearanceCompleted with Results
Inhaled Dry Powder Mannitol in Cystic Fibrosis , protocol number Pharmaxis DPM-CF-302This Phase 3 study looked at the safety and effectiveness of treatment with inhaled dry powder mannitol.
-
Age:
6 Years and Older
-
Mutation(s):
No Mutation Requirement
-
FEV1% Predicted:
30 to 89%
-
Number of Visits:
7
-
Length of Participation:
52 weeks
-
Showing 1-2 of 2 studies
- 1
Studies in this tool are multi-center studies facilitated by the Cystic Fibrosis Therapeutics Development Network. For a complete list of cystic fibrosis related studies, visit www.clinicaltrials.gov.
Related Topics
CONTACT THE CLINICAL TRIAL NAVIGATOR
Get personalized assistance and answers to your clinical trial questions.
Learn MoreSign up for clinical trial alerts
Get email updates about clinical trials that matter to you.
Check the Drug Development Pipeline
We’re attacking CF from every angle. Learn about the status of CF drugs in development.
Learn More